Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Magnetic Resonance Imaging Mri 3 Tesla

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04021485Not ApplicableCompletedPrimary

BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation

NCT03972761Not ApplicableUnknownPrimary

Evaluation of Brain Plasticity in Premature Infants at School Age After Cognitive Remediation

Showing all 2 trials

Research Network

Common Treatments

  • Magnetic Resonance Imaging Mri 3 Tesla1
  • Neurodevelopmental Assessment1

Active Sponsors

  • Assistance Publique Hopitaux De Marseille1
  • Assistance Publique - Hôpitaux de Paris1

Top Investigators

Activity Timeline